These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22958144)

  • 1. Periodontal ligament cells cultured under steady-flow environments demonstrate potential for use in heart valve tissue engineering.
    Martinez C; Rath S; Van Gulden S; Pelaez D; Alfonso A; Fernandez N; Kos L; Cheung H; Ramaswamy S
    Tissue Eng Part A; 2013 Feb; 19(3-4):458-66. PubMed ID: 22958144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology.
    Engelmayr GC; Soletti L; Vigmostad SC; Budilarto SG; Federspiel WJ; Chandran KB; Vorp DA; Sacks MS
    Ann Biomed Eng; 2008 May; 36(5):700-12. PubMed ID: 18253834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan entrapment by fibrin in engineered heart valve tissues.
    Alfonso AR; Rath S; Rafiee P; Hernandez-Espino M; Din M; George F; Ramaswamy S
    Acta Biomater; 2013 Sep; 9(9):8149-57. PubMed ID: 23791855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype.
    Rath S; Salinas M; Villegas AG; Ramaswamy S
    PLoS One; 2015; 10(11):e0141802. PubMed ID: 26536240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.
    Ramaswamy S; Gottlieb D; Engelmayr GC; Aikawa E; Schmidt DE; Gaitan-Leon DM; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2010 Feb; 31(6):1114-25. PubMed ID: 19944458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
    Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
    Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-dependent re-endothelialization of tissue-engineered heart valves.
    Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
    J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous human tissue-engineered heart valves: prospects for systemic application.
    Mol A; Rutten MC; Driessen NJ; Bouten CV; Zünd G; Baaijens FP; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I152-8. PubMed ID: 16820565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
    Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA
    Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering.
    VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA
    Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A "sweet-spot" for fluid-induced oscillations in the conditioning of stem cell-based engineered heart valve tissues.
    Williams A; Nasim S; Salinas M; Moshkforoush A; Tsoukias N; Ramaswamy S
    J Biomech; 2017 Dec; 65():40-48. PubMed ID: 29054608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-operated growth inhibition and translineage commitment into smooth muscle cells of periodontal ligament-derived endothelial progenitor cells through Smad- and p38 MAPK-dependent signals.
    Yoshida M; Okubo N; Chosa N; Hasegawa T; Ibi M; Kamo M; Kyakumoto S; Ishisaki A
    Int J Biol Sci; 2012; 8(7):1062-74. PubMed ID: 22949889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.
    Ramaswamy S; Boronyak SM; Le T; Holmes A; Sotiropoulos F; Sacks MS
    J Biomech Eng; 2014 Dec; 136(12):121009. PubMed ID: 25321615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach.
    Mol A; Driessen NJ; Rutten MC; Hoerstrup SP; Bouten CV; Baaijens FP
    Ann Biomed Eng; 2005 Dec; 33(12):1778-88. PubMed ID: 16389526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational simulations predict a key role for oscillatory fluid shear stress in de novo valvular tissue formation.
    Salinas M; Ramaswamy S
    J Biomech; 2014 Nov; 47(14):3517-23. PubMed ID: 25262874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
    Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.